SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Form 8.5 (EPT/RI)

15 May 2024 11:16

RNS Number : 5604O
Canaccord Genuity Limited
15 May 2024
Β 

-

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

Β 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

The Mission Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected to the Offeree

Β 

(d) Date dealing undertaken:

14 May 2024

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Β 

Ord 1p

Β 

Β 

Purchases

Β 

49,901

Β 

23.5p

Β 

23.5p

Β 

Ord 1p

Β 

Β 

Sales

Β 

22,440

Β 

24.5p

Β 

24.5p

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

Β 

Date of disclosure:

15 May 2024

Contact name:

David Baker

Telephone number:

020 7523 4656

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FERMZGMKGKFGDZM
Date   Source Headline
5th Jun 201912:03 pmRNSEBT Share Dealings
4th Jun 20197:00 amRNSGrowth Share Scheme
20th May 20195:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20192:36 pmRNSDirector/PDMR Shareholding
23rd Apr 20199:53 amRNSDirector/PDMR Shareholding
9th Apr 20197:01 amRNSIssue of Equity
9th Apr 20197:00 amRNSFinal Results & Board Changes
22nd Jan 20197:00 amRNSTrading update and Notice of results
5th Dec 20181:43 pmRNSDirector/PDMR Shareholding
23rd Nov 20185:25 pmRNSDirector/PDMR Shareholding
15th Nov 20187:00 amRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSDisposal
19th Sep 20187:00 amRNSHalf-year Report
26th Jul 20187:00 amRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSTrading update and notice of interim results
10th Jul 20187:00 amRNSBoard changes
19th Jun 20182:33 pmRNSResult of AGM
22nd May 20182:11 pmRNSEBT Share Dealings
22nd May 20182:11 pmRNSHolding(s) in Company
9th May 20182:51 pmRNSDirector/PDMR Shareholding
19th Apr 20187:00 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSAcquisition of Krow Communications
10th Apr 20187:00 amRNSFinal Results
25th Jan 20187:00 amRNSTrading Statement
6th Dec 201710:15 amRNSDirector/PDMR Shareholding
31st Oct 20171:41 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSHolding(s) in Company
16th Oct 20173:33 pmRNSDirector/PDMR Shareholding
6th Oct 20172:47 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSHalf-year Report
4th Sep 20177:00 amRNSChange of Adviser
1st Aug 20177:00 amRNSLTIP Options
27th Jul 201710:11 amRNSLTIP Options
24th Jul 20177:00 amRNSTrading Update and Notice of Results
19th Jun 20172:01 pmRNSResult of AGM
27th Apr 20177:40 amRNSAcquisition of RJW & Partners
23rd Mar 20177:00 amRNSAudited results for the year to 31 December 2016
6th Mar 20177:00 amRNSBoard Changes
22nd Feb 20177:00 amRNSGrowth Share Scheme
19th Jan 20177:00 amRNSTrading Update, Growth Shares & Notice of Results
12th Dec 20167:00 amRNSDirectors Dealing
25th Nov 20167:00 amRNSDirector Dealing
18th Nov 20167:00 amRNSReceipt of Industry Awards
12th Oct 20163:30 pmRNSDirector/PDMR Shareholding
10th Oct 20167:00 amRNSLaunch of new Sales Promotion business
22nd Sep 20167:00 amRNSHalf-year Report
21st Jul 20167:00 amRNSTrading update and notice of results
14th Jun 20162:58 pmRNSResult of AGM
17th May 20163:56 pmRNSLTIP Awards
31st Mar 20163:34 pmRNSIssue of deferred consideration shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.